Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP05 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      FP05.02 - A Biomarker-Directed, Multi-Center Phase II Study of Molecular Response Adaptive Immuno-Chemotherapy in Lung Cancer

      00:00 - 00:00  |  Presenter: Valsamo Anagnostou

      • Abstract

      Loading...

  • +

    FP07 - Mesothelioma, Thymoma and Other Thoracic Malignancies

    • 00:00 - 00:00
    • 9/08/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters (Featured)
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      FP07.05 - DREAM3R: Durvalumab With Chemotherapy as First Line Treatment in Advanced Pleural Mesothelioma - A Phase 3 Randomised Trial

      00:00 - 00:00  |  Presenter: Anna Nowak

      • Abstract

      Loading...

  • +

    PL02 - Plenary 2: Presidential Symposium (Japanese, Mandarin, Spanish Translation Available)

    • 06:30 - 08:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02.02 - Discussant

      06:40 - 06:47  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

  • +

    OA12 - Understanding and Augmenting Responses to Immunotherapy for Thoracic Malignancies

    • 12:00 - 13:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Tumor Biology and Systems Biology: Basic and Translational Science
    • +

      OA12.01 - Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma

      12:00 - 12:10  |  Presenter: Valsamo Anagnostou

      • Abstract

      Loading...

  • +

    PL02A - Plenary 2: Presidential Symposium (Rebroadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 14:30 - 16:00
    • 9/09/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL02A.02 - Discussant

      14:40 - 14:47  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation

  • +

    IS15 - Satellite CME Symposium by Clinical Care Options: Understanding the Evolving Immuno-Oncology Treatment Paradigm in Non-Small-Cell Lung Cancer

    • 15:00 - 16:00
    • 9/14/2021
    • Location: Program Auditorium
    • CME Accredited by Other Provider
    • Type: Satellite CME Symposia
    • Track: N.A.
    • +

      IS15.03 - Evolving Role of Immunotherapy in Advanced or Metastatic NSCLC

      15:20 - 15:45  |  Presenter: Julie Brahmer

      • Abstract

      No abstract available for this presentation